ADMA BIOLOGICS INC (NASDAQ:ADMA) – A High Growth Momentum Stock with Strong Technical Setup
By Mill Chart
Last update: Jun 7, 2025
ADMA BIOLOGICS INC (NASDAQ:ADMA) stands out as a high-growth momentum candidate with a solid technical setup, according to our screening criteria. The company, which specializes in plasma-derived biologics, has demonstrated strong earnings and revenue growth while maintaining a favorable technical structure for potential breakout opportunities.
Growth Momentum Highlights
- Exceptional Earnings Growth: ADMA reported a staggering 2,750% year-over-year EPS growth (TTM), with recent quarterly EPS growth rates of 37.5% (Q2Q) and 275% (previous quarter).
- Revenue Expansion: Sales growth remains robust, with a 62.2% increase over the past year and consistent quarterly growth above 40%.
- Profit Margins: The company maintains strong profitability, with a trailing twelve-month profit margin of 46.35%. Recent quarters have shown margins as high as 95.19%.
- Analyst Confidence: While recent EPS and revenue estimate revisions have been slightly negative (-4.69%), the company has a history of beating expectations, with an average EPS surprise of 8.19% over the last four quarters.
Technical Strength & Setup
- Technical Rating (8/10): ADMA’s stock is in a long-term uptrend, outperforming 95% of all stocks in the market and 93% of its biotechnology peers.
- Setup Quality (8/10): The stock is consolidating within an $18.95–$21.48 range, presenting a potential breakout opportunity above $20.62. Support is firm near $20.12, providing a clear risk level.
- Relative Strength: The stock ranks in the top 5% of the market based on relative performance over the past year.
For a deeper technical breakdown, review the full technical report for ADMA.
Our High Growth Momentum Breakout Setups Screen lists more stocks with similar characteristics and is updated daily.
Disclaimer
This is not investment advice. The observations here are based on current data, but market conditions can change. Always conduct your own research before making investment decisions.
